ℹ️ Compiled from public regulatory records · Last regulator revision: February 27, 2026🚩 Report this page
Plozasiran
Active ingredient
Sold as REDEMPLO
CA Health Canada
- Drug class
- -
- Availability
- See label
- Routes
- Subcutaneous
- Markets covered
- 1
- Products on record
- 1
Overview
Plozasiran is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 1 | February 27, 2026 |
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Brands in Canada (1)
Sources & citations
- [1]Health Canada (DPD) · 02564327 · revised February 27, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.